The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
May. 13, 2003
Filed:
May. 19, 2000
László Balázs, Budapest, HU;
József Barkóczy, Budapest, HU;
Imre Domán, Budapest, HU;
András Egyed, Budapest, HU;
Istvän Gacsályi, Budapest, HU;
Gábor Gigler, Budapest, HU;
Zoltán Greff, Budapest, HU;
István Gyertyán, Budapest, HU;
Péter Kótay Nagy, Vác, HU;
Attila Kovács, Dorog, HU;
György Lávay, Budakeszi, HU;
Zoltán Rátkai, Budapest, HU;
Péter Seres, Budapest, HU;
Gyula Simig, Budapest, HU;
Annamária Simó, Budapest, HU;
Tamás Szabados, Budapest, HU;
Géza Szabó, Budapest, HU;
Károly Tihanyi, Budapest, HU;
Miklós Végh, Budapest, HU;
Géza Schneider, Budapest, HU;
Judit Cselenyák, Budapest, HU;
Egis Gyogyszergyar RT., Budapest, HU;
Abstract
The disclosure relates to a novel 8-substituted-9H-1,3-dioxolo-[4,5-h][2,3]benzodiazepine compound of formula I and pharmaceutically acceptable quaternary ammonium salts thereof, a process for preparing the same, a pharmaceutical composition containing a 8-substituted-9H-1,3-dioxolo-[4,5-h][2,3]benzodiazepine compound, and a method of treatment using the pharmaceutical composition. A complete description of the compound of formula I is found in the specification. The compounds of the general formula I possess unique competitive AMPA/kainite antagonist properties making them useful in the treatment of diseases where inhibition of the AMPA/kainite receptors may a favorable effect.